Three pronged approach puts brakes on US breast cancer
Tuesday, January 15, 2013 - 05:01
in Health & Medicine
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via